The DOI matches its Crossref record; 562 of the 562 references it cites were found in a registry or an index.
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
Open accessAbstract
Cancer reprogramming is an important facilitator of cancer development and survival, with tumor cells exhibiting a preference for aerobic glycolysis beyond oxidative phosphorylation, even under sufficient oxygen supply condition. This metabolic alteration, known as the Warburg effect, serves as a significant indicator of malignant tumor transformation. The Warburg effect primarily impacts cancer occurrence by influencing the aerobic glycolysis pathway in cancer cells. Key enzymes involved in this process include glucose transporters (GLUTs), HKs, PFKs, LDHs, and PKM2. Moreover, the expression of transcriptional regulatory factors and proteins, such as FOXM1, p53, NF-κB, HIF1α, and c-Myc, can also influence cancer progression. Furthermore, lncRNAs, miRNAs, and circular RNAs play a vital role in directly regulating the Warburg effect. Additionally, gene mutations, tumor microenvironment remodeling, and immune system interactions are closely associated with the Warburg effect. Notably, the development of drugs targeting the Warburg effect has exhibited promising potential in tumor treatment. This comprehensive review presents novel directions and approaches for the early diagnosis and treatment of cancer patients by conducting in-depth research and summarizing the bright prospects of targeting the Warburg effect in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
5 retracted
Items 401–562 of 562
The Warburg effect: molecular aspects and therapeutic possibilities
Ngo, H. G., Tortorella, S. M., Ververis, K., & Karagiannis, T. C. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3764-7 · Cited by 83
Neil, J. R., & Schiemann, W. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3094 · Cited by 83
Shi, Y., Zhang, Y., Ran, F., Liu, J., Lin, J., Hao, X., Ding, L., & Ye, Q. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.09.012 · Cited by 83
Remels, A. H. V., Gosker, H. R., Verhees, K. J. P., Langen, R. C. J., & Schols, A. M. W. J. (2015) · Endocrinology · doi:10.1210/en.2014-1591 · Cited by 82
Law, C., Wei, L., Tsang, F. H., Chan, C. Y., Xu, M., Lai, R. K., Ho, D. W., Lee, J. M., Wong, C. C., Ng, I. O., et al. (2018) · Hepatology · doi:10.1002/hep.30414 · Cited by 82
miR-885-5p Negatively Regulates Warburg Effect by Silencing Hexokinase 2 in Liver Cancer
Xu, F., Yan, J., Gan, Y., Chang, Y., Wang, H., He, X., & Zhao, Q. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.09.002 · Cited by 82
Hamann, I., Krys, D., Glubrecht, D. D., Bouvet, V., Marshall, A., Vos, L. J., Mackey, J. R., Wuest, M., & Wuest, F. R. (2018) · The FASEB Journal · doi:10.1096/fj.201800360r · Cited by 81
Li, D., Wang, C., Ma, P., Yu, Q., Gu, M., Dong, L., Jiang, W., Pan, S., Xie, C., Han, J., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0494-0 · Cited by 81
Efficient Elimination of Cancer Cells by Deoxyglucose-ABT-263/737 Combination Therapy
Yamaguchi, R., Janssen, E. M., Perkins, G. A., Ellisman, M. H., Kitada, S., & Reed, J. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024102 · Cited by 80
Fresquet, V., Garcia-Barchino, M. J., Larráyoz, M., Celay, J., Vicente, C., Fernández‐Galilea, M., Larráyoz, M. J., Calasanz, M. J., Panizo, C., Junza, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1065 · Cited by 80
Yang, H., Zhu, R., Zhao, X., Liu, L., Zhou, Z., Zhao, L., Liang, B., Ma, W., Zhao, J., Liu, J., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0764-z · Cited by 79
Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer
Suh, D. H., Kim, M. A., Kim, H., Kim, M., Kim, H. S., Chung, H. H., Kim, Y.-B., & Song, Y. S. (2013) · Clinical and Experimental Medicine · doi:10.1007/s10238-013-0250-9 · Cited by 78
Tavares‐Valente, D., Baltazar, F., Moreira, R. F., & Queirós, O. (2013) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-013-9519-7 · Cited by 78
Wang, T., Zhang, X., GUO, X.-Y., Xian, S.-L., & Lu, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.4511 · Cited by 78
CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesis
Li, W., Wong, C. C., Zhang, X., Kang, W., Nakatsu, G., Zhao, Q., Chen, H., Go, M. Y. Y., Chiu, P. W. Y., Wang, X., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0402-1 · Cited by 78
Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells
Hu, C., Pang, B., Lin, G., Yu, Z., & Yi, H. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0644-x · Cited by 78
Mechanism of PKM2 affecting cancer immunity and metabolism in Tumor Microenvironment
Chen, M., Liu, H., Li, Z., Ming, A. L., & Chen, H. (2021) · Journal of Cancer · doi:10.7150/jca.54430 · Cited by 78
Liu, J., Wu, N., Ma, L., Liu, M., Liu, G., Zhang, Y., & Lin, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091606 · Cited by 77
18F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer
Ulaner, G. A., Castillo, R., Goldman, D. A., Wills, J., Riedl, C. C., Pinker, K., Jochelson, M. S., & Gönen, M. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3402-9 · Cited by 77
Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells
Agnihotri, S., Mansouri, S., Burrell, K. E., Li, M., Mamatjan, Y., Liu, J., Nejad, R., Kumar, S., Jalali, S., Singh, S. K., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1854 · Cited by 77
Regulation and Cytoprotective Role of Hexokinase III
Wyatt, E. J., Wu, R., Rabeh, W. M., Park, H.-W., Ghanefar, M., & Ardehali, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013823 · Cited by 76
Inhibition of Glucose Transporter 1 (GLUT1) Chemosensitized Head and Neck Cancer Cells to Cisplatin
Wang, Y., Li, S., & Liao, J.-X. (2013) · Technology in Cancer Research & Treatment · doi:10.7785/tcrt.2012.500343 · Cited by 76
Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal Cells
Kim, J. T., Li, C., Weiss, H. L., Zhou, Y., Liu, C., Wang, Q., & Evers, B. M. (2019) · Cells · doi:10.3390/cells8091106 · Cited by 75
Li, M., Gao, F., Zhao, Q., Zuo, H., Liu, W., & Li, W. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2579-9 · Cited by 75
Ovarian tumor-initiating cells display a flexible metabolism
Anderson, A. S., Roberts, P. C., Frisard, M. I., Hulver, M. W., & Schmelz, E. M. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.08.028 · Cited by 73
Sun, L., Lü, T., Tian, K., Zhou, D., Yuan, J., Wang, X., Zhu, Z., Wan, D., Yao, Y., Zhu, X., et al. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.12.035 · Cited by 73
Feng, C., Li, Y., Li, K., Lyu, Y., Zhu, W., Jiang, H., & Wen, H. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02103-5 · Cited by 73
Gu, Y. J., Qi, C., Sun, X., Ma, X., Zhang, H., Hu, L., Yuan, J., & Yu, Q. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.06.002 · Cited by 72
Wang, Y., Qu, C., Liu, T., & Wang, C. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112612 · Cited by 72
Xia, F., Zhao, P., Gao, S., Liu, D., Zhang, S., Shan, M., Wang, Y., Herrmann, J., Li, Q., & Wang, F. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123810 · Cited by 72
Chen, G., Tang, C., Shi, X., Lin, C., Fatima, S., Pan, X., Yang, D., Zhang, G., Lü, A., Lin, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4376 · Cited by 71
HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer
Pudova, E. A., Kudryavtseva, A. V., Fedorova, M., Zaretsky, A. R., Shcherbo, D. S., Lukyanova, E., Popov, A., Садритдинова, А. Ф., Abramov, I. S., Kharitonov, S., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-4477-4 · Cited by 71
Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer
Eastlack, S. C., Dong, S., Ivan, C., & Alahari, S. K. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0851-8 · Cited by 71
Deng, X., Zhao, J., Qu, L., Duan, Z., Fu, R., Zhu, C., & Fan, D. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114038 · Cited by 71
Metabolic changes during ovarian cancer progression as targets for sphingosine treatment
Anderson, A. S., Roberts, P. C., Frisard, M. I., McMillan, R. P., Brown, T. J., Lawless, M. H., Hulver, M. W., & Schmelz, E. M. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.02.017 · Cited by 69
Lucarelli, G. T., Rutigliano, M., Sanguedolce, F., Galleggiante, V., Giglio, A., Cagiano, S., Bufo, P., Maiorano, E., Ribatti, D., Ranieri, E., et al. (2015) · Medicine · doi:10.1097/md.0000000000002117 · Cited by 69
Liang, Y., Zhang, D., Zheng, T., Yang, G., Wang, J., Meng, F., Liu, Y., Zhang, G., Zhang, L., Han, J., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-0242-z · Cited by 69
Dai, Y., Liu, Y., Li, J., Jin, M., Yang, H., & Huang, G. (2022) · Bioengineered · doi:10.1080/21655979.2022.2086378 · Cited by 69
Mishra, R. K., Wei, C., Hresko, R. C., Bajpai, R., Heitmeier, M. R., Matulis, S. M., Nooka, A. K., Rosen, S. T., Hruz, P. W., Schiltz, G. E., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.628826 · Cited by 67
HIF-1 as a Target for Cancer Chemotherapy, Chemosensitization and Chemoprevention
Monti, E., & Gariboldi, M. B. (2011) · Current Molecular Pharmacology · doi:10.2174/1874-470211104010062 · Cited by 67
Xiang, Z., Xu, C., Wu, G., Liu, B., & Wu, D. (2019) · Open Medicine · doi:10.1515/med-2019-0097 · Cited by 67
Self-citationLeung, E., Cairns, R. A., Chaudary, N., Vellanki, R. N., Kalliomäki, T., Moriyama, E. H., Mujčić, H., Wilson, B. C., Wouters, B. G., Hill, R. P., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3402-6 · Cited by 66
Zhang, C., Cai, T., Zeng, X., Cai, D., Chen, Y., Huang, X., Gan, H., Zhuo, J., Zhao, Z., Pan, H., et al. (2018) · Phytotherapy Research · doi:10.1002/ptr.6070 · Cited by 66
Du, Y., Wei, N., Ma, R., Jiang, S., & Song, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.580176 · Cited by 66
Tsai, T., Yang, C., Kou, T., Yang, C., Dai, J., Chen, C., & Lin, C. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30189 · Cited by 66
Jena, B. C., Das, C. K., Banerjee, I., Bharadwaj, D., Majumder, R., Das, S., Biswas, A., Kundu, M., Roy, P., Kundu, C. N., et al. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113195 · Cited by 66
Regulation of Carbohydrate Metabolism(1985)
(2018) · CRC Press eBooks · doi:10.1201/9781351076265 · Cited by 65
Ferraro, E., Germanò, M., Mollace, R., Mollace, V., & Malara, N. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8841911 · Cited by 65
Fodor, T., Szántó, M., Abdul-Rahman, O., Nagy, L., Dér, Á., Kiss, B., & Bai, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150232 · Cited by 64
ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.12.014 · Cited by 64
Wu, X., Qian, S., Zhang, J., Feng, J., Luo, K., Sun, L., Zhao, L., Ran, Y., Sun, L., Wang, J., et al. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00260-x · Cited by 64
Self-citationNKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition
Zhang, W., Guo, Q., Liu, G., Zheng, F., Chen, J., Huang, D., Ding, L., Yang, X., Song, E., Xiang, Y., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008325 · Cited by 62
Lin28A promotes IRF6-regulated aerobic glycolysis in glioma cells by stabilizing SNHG14
Lu, J., Liu, X., Zheng, J., Song, J., Liu, Y., Ruan, X., Shen, S., Shao, L., Yang, C., Wang, D., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2650-6 · Cited by 62
Abouzeid, A. H., Patel, N. R., Rachman, I. M., Senn, S., & Torchilin, V. P. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.840639 · Cited by 61
Li, W., Liu, J., & Zhao, Y. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21988 · Cited by 61
Reduced expression of the H19 long non-coding RNA inhibits pancreatic cancer metastasis
Yoshimura, H., Matsuda, Y., Yamamoto, M., Michishita, M., Takahashi, K., Sasaki, N., Ishikawa, N., Aida, J., Takubo, K., Arai, T., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0048-1 · Cited by 61
Huang, X., Zhong, R. M., He, X., Deng, Q., Peng, X., Li, J., & Luo, X. (2018) · IUBMB Life · doi:10.1002/iub.1959 · Cited by 61
Expression of Autocrine Motility Factor (AMF) and Its Receptor, AMFR, in Human Breast Cancer
Jiang, W. G., Raz, A., Douglas-Jones, A. G., & Mansel, R. E. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6785.2005 · Cited by 60
Zhu, J., Zheng, Y., Zhang, H., & Sun, H. (2016) · PubMed · Cited by 60
Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer
Liu, Z., Zhu, W., Kong, X., Chen, X., Sun, X., Zhang, W., & Zhang, R. (2019) · Oncology Reports · doi:10.3892/or.2019.7294 · Cited by 60
Schmidt, K., Lucignani, G., & Sokoloff, L. (1996) · PubMed · Cited by 59
Middleton, R. J. (1990) · Biochemical Society Transactions · doi:10.1042/bst0180180 · Cited by 59
Yang, L., Zhang, W., Wang, Y., Zou, T., Zhang, B., Xu, Y., Pang, T., Hu, Q., Chen, M., Wang, L., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.007 · Cited by 59
GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets
Guda, M. R., Labak, C. M., Omar, S. I., Asuthkar, S., Airala, S., Tuszyński, J. A., Tsung, A. J., & Velpula, K. K. (2019) · Cancers · doi:10.3390/cancers11091308 · Cited by 59
Ding, Y., Xue, Q., Liu, S., Hu, K., Wang, D., Wang, T., Li, Y., Guo, H., Hao, X., Ge, W., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01328 · Cited by 58
Zhang, C., Liu, Q., Li, M., Lin, S., Peng, Y., Wu, D., Li, T. Y., Fu, Q., Jia, W., Wang, X., et al. (2015) · Cell Research · doi:10.1038/cr.2015.90 · Cited by 57
Hosnijeh, F. S., Lan, Q., Rothman, N., Liu, C. S., Cheng, W.-L., Nieters, A., Guldberg, P., Tjønneland, A. M., Campa, D., Martino, A., et al. (2014) · Blood · doi:10.1182/blood-2013-10-532085 · Cited by 57
Hirono, Y., Fushida, S., Yonemura, Y., Yamamoto, H., Watanabe, H., & Raz, A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.667 · Cited by 57
Aptamer‑T Cell Targeted Therapy for Tumor Treatment Using Sugar Metabolism and Click Chemistry
Liu, C.-G., Wang, Y., Liu, P., Yao, Q., Zhou, Y., Li, C., Zhao, Q., Liu, G., & Zhang, X. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00164 · Cited by 56
Zhu, W., Li, Y., Zhao, D., Li, H.-L., Zhang, W., Xu, J., Hou, J., Feng, X., & Wang, H. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116730 · Cited by 55
Shinohara, Y., Yamamoto, K., Kogure, K., Ichihara, J., & Terada, H. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90142-2 · Cited by 54
Epigallocatechin gallate inhibits human tongue carcinoma cells via HK2-mediated glycolysis
Gao, F., Li, M., Liu, W., ZHOU, Z.-S., Zhang, R., LI, J.-L., & Zhou, K. (2015) · Oncology Reports · doi:10.3892/or.2015.3727 · Cited by 53
Fumarate Hydratase Deficiency and Cancer: Activation of Hypoxia Signaling?
Ratcliffe, P. J. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.015 · Cited by 52
He, Z., Dang, J., Song, A., Cui, X., Ma, Z., & Zhang, Z. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28557 · Cited by 52
Xu, C., Tsai, Y., Galbo, P. M., Gong, W., Storey, A. J., Xu, Y., Byrum, S. D., Xu, L., Whang, Y. E., Parker, J. S., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab252 · Cited by 52
Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer
Peng, X., Gong, F. M., Chen, Y., Qiu, M., Cheng, K., Tang, J., Ge, J., Chen, N., Zeng, H., & Liu, J. Y. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.11.027 · Cited by 51
Advances in glucose metabolism research in colorectal cancer
Fang, S., & Fang, X. (2016) · Biomedical Reports · doi:10.3892/br.2016.719 · Cited by 51
Kang, S. A., O’Neill, D. J., Machl, A. W., Lumpkin, C. J., Galda, S. N., Sengupta, S., Mahoney, S. J., Howell, J. J., Molz, L., Hahm, S., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.05.009 · Cited by 51
Nuclear Imaging of Glucose Metabolism: Beyond 18F-FDG
Feng, H., Wang, X., Chen, J., Cui, J. R., Gao, T., Gao, Y., & Zeng, W. (2019) · Contrast Media & Molecular Imaging · doi:10.1155/2019/7954854 · Cited by 50
Bhattacharya, S. S., Thirusangu, P., Jin, L., Roy, D., Jung, D., Xiao, Y., Staub, J. K., Roy, B., Molina, J. R., & Shridhar, V. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1916-3 · Cited by 50
Identification of novel GLUT inhibitors
Siebeneicher, H., Bauser, M., Buchmann, B., Heisler, I., Müller, T. H., Neuhaus, R., Rehwinkel, H., Telser, J., & Zorn, L. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.02.050 · Cited by 49
Ebron, J. S., Shankar, E., Singh, J., Sikand, K., Weyman, C. M., Gupta, S., Lindner, D. J., Liu, X., Campbell, M. J., & Shukla, G. C. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2993 · Cited by 49
Bezielle Selectively Targets Mitochondria of Cancer Cells to Inhibit Glycolysis and OXPHOS
Chen, V., Staub, R. E., Fong, S., Tagliaferri, M. A., Cohen, I. V., & Shtivelman, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030300 · Cited by 48
Fu, Y., Wang, B., Tseng, J., Huang, S., Lin, C., Kuo, Y., Hour, T., & Chuu, C. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00797-z · Cited by 48
Arachidonic acid induction of Rho-mediated transendothelial migration in prostate cancer
Brown, M. D., Roulson, J. A., Hart, C. A., Tawadros, T., & Clarke, N. W. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.99 · Cited by 47
LIU, G., LI, Y., & Gao, X. (2016) · Oncology Letters · doi:10.3892/ol.2016.4316 · Cited by 47
Ning, X., Qi, H., Li, R., Jin, Y., McNutt, M. A., & Yin, Y. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1404591 · Cited by 47
Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression
Barnabas, G. D., Lee, J. S., Shami, T., Harel, M., Beck, L., Selitrennik, M., Jerby‐Arnon, L., Erez, N., Ruppin, E., & Geiger, T. (2021) · Cancer Research · doi:10.1158/0008-5472.can-19-3020 · Cited by 47
Shao, X., Zheng, X., Ma, D., Liu, Y., & Liu, G. (2021) · Bioscience Reports · doi:10.1042/bsr20200533 · Cited by 47
Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer
Ruscetti, M., Morris, J. P., Mezzadra, R., Russell, J., Leibold, J., Romesser, P. B., Simon, J., Kulick, A., Ho, Y.-J., Fennell, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.028 · Cited by 46
Jin, F., Bao, Y., Zhou, S., & Fan, J. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4233 · Cited by 46
Building GLUT4 Vesicles: CHC22 Clathrin’s Human Touch
Gould, G. W., Brodsky, F. M., & Bryant, N. J. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.05.007 · Cited by 46
Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma
Berlth, F., Mönig, S., Pinther, B., Grimminger, P., Maus, M. K. H., Schlößer, H., Plum, P. S., Warnecke‐Eberz, U., Harismendy, O., Drebber, U., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4730-x · Cited by 45
W arburg effect regulated by amphiregulin in the development of colorectal cancer
Nam, S. O., Yotsumoto, F., Miyata, K., Fukagawa, S., Yamada, H., Kuroki, M., & Miyamoto, S. (2015) · Cancer Medicine · doi:10.1002/cam4.416 · Cited by 44
Identification of upregulated genes in oral squamous cell carcinomas
Lessa, R. C., Campos, A. H. J. F. M., de Freitas, C. E., da Silva, F. R., Kowalski, L. P., Carvalho, A. L., & Vettore, A. L. (2012) · Head & Neck · doi:10.1002/hed.23169 · Cited by 44
Lea, M. A., Guzman, Y., & desBordes, C. (2016) · PubMed · Cited by 44
Dai, Q., Yin, Q., Wei, L., Zhou, Y., Qiao, C., Guo, Y., Wang, X., Ma, S., & Lu, N. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22369 · Cited by 43
MicroRNA-214 promotes peritoneal metastasis through regulating PTEN negatively in gastric cancer
Xin, R., Bai, F., Feng, Y., Jiu, M., Liu, X., Bai, F., Nie, Y., & Fan, D. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.05.006 · Cited by 43
Shi, D., Zhao, D., Niu, P., Zhu, Y., Zhou, J., & Chen, H. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2380-9 · Cited by 43
Chen, C., Meng, W., Wang, C., Sun, D., Liu, P., Zhong, X., & Yu, W. (2020) · Aging · doi:10.18632/aging.103334 · Cited by 43
Shima, T., Taniguchi, K., Tokumaru, Y., Inomata, Y., Arima, J., Lee, S., Takabe, K., Yoshida, K., & Uchiyama, K. (2021) · Oncology Reports · doi:10.3892/or.2021.8218 · Cited by 43
Inhibition of PKM2 Enhances Sensitivity of Olaparib to Ovarian Cancer Cells and Induces DNA Damage
Zhou, S., Li, D., Xiao, D., Wu, T., Hu, X., Zhang, Y., Deng, J., Long, J., Xu, S., Wu, J., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.62947 · Cited by 43
Tang, W.-R., Fang, J., Wu, K., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.16.6929 · Cited by 42
Fenofibrate Induces Ketone Body Production in Melanoma and Glioblastoma Cells
Grabacka, M., Wilk, A. M., Antończyk, A., Banks, P., Walczyk-Tytko, E., Dean, M. J., Pierzchalska, M., & Reiss, K. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00005 · Cited by 42
MicroRNA regulation and analytical methods in cancer cell metabolism
Zhang, L.-F., Jiang, S., & Liu, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2508-y · Cited by 42
Yao, L., Wang, L., Cao, Z.-G., Hu, X., & Shao, Z. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0882-2 · Cited by 42
Yu, L., Hu, Q., & Gu, J. (2019) · Pathology & Oncology Research · doi:10.1007/s12253-019-00708-y · Cited by 41
Emerging Roles and Research Tools of Atypical Ubiquitination
Huang, Q., & Zhang, X. (2020) · PROTEOMICS · doi:10.1002/pmic.201900100 · Cited by 41
Sun, W., Li, A., Zhou, P., Jiang, Y., Jin, X., Liu, Y., Guo, Y., Yang, W., Shao, Z., & Xu, X. (2018) · Cancer Medicine · doi:10.1002/cam4.1603 · Cited by 40
Energy sources identify metabolic phenotypes in pancreatic cancer
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw097 · Cited by 39
HIC1 and miR-23~27~24 clusters form a double-negative feedback loop in breast cancer
Wang, Y., Liang, H., Zhou, G., Hu, X., Liu, Z., Jin, F., Yu, M., Sang, J., Zhou, Y., Fu, Z., et al. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2016.136 · Cited by 38
Hussain, A., Qazi, A. K., Mupparapu, N., Guru, S. K., Kumar, A., Sharma, P. R., Singh, S. K., Singh, P., Dar, M. J., Bharate, S. B., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.030 · Cited by 38
Therapeutic Targeting of Cancer Metabolism with Triosephosphate Isomerase
Pekel, G., & Arı, F. (2020) · Chemistry & Biodiversity · doi:10.1002/cbdv.202000012 · Cited by 38
A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1
Libby, C. J., Sajina, G. C., Benavides, G. A., Fisher, J. L., Williford, S. E., Zhang, S., Tran, A. N., Gordon, E. R., Jones, A. B., Tuy, K., et al. (2021) · Cell Adhesion & Migration · doi:10.1080/19336918.2021.1903684 · Cited by 38
Liu, W., Pan, H., Yang, L., Zhao, Z., Yuan, D.-S., Liu, Y., & Lin, L. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/2672648 · Cited by 37
Richardson, D. A., Sritangos, P., James, A. D., Sultan, A. M., & Bruce, J. I. E. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-0210-2 · Cited by 36
Huang, Y. C., Xian, L., Liu, Z., Wei, L., Qin, L., Xiong, Y., Hu, L., Zhou, S., Fu, Q., Li, B., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115198 · Cited by 36
Wu, L., Xu, J., Yuan, W., Wu, B., Wang, H., Liu, G., Wang, X., Du, J., & Cai, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112132 · Cited by 35
Self-citationMethyljasmonate displays in vitro and in vivo activity against multiple myeloma cells
Klippel, S., Jakubíková, J., Delmore, J. E., Ooi, M. G. M., McMillin, D. W., Kastritis, E., Laubach, J. P., Richardson, P. G. G., Anderson, K. C., & Mitsiades, C. S. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09253.x · Cited by 35
Tumor bioenergetics: An emerging avenue for cancer metabolism targeted therapy
Kee, H. J., & Cheong, J. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.3.273 · Cited by 35
Chemical profile of Xian-He-Cao-Chang-Yan formula and its effects on ulcerative colitis
Li, J., Li, M., Ye, K., Jiang, Q., Wang, M., Wen, X., & Yang, J. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113517 · Cited by 35
Cho, M., Park, C. K., Park, M., Kim, W. K., Cho, A. E.-H., & Kim, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141413 · Cited by 34
Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report
Pujol‐Giménez, J., de Heredia, F. P., Idoate, M. A., Airley, R. E., Lostao, M. P., & Evans, A. R. (2015) · Journal of Cancer · doi:10.7150/jca.10429 · Cited by 33
Matthews, R., & Choi, M. (2016) · Diagnostics · doi:10.3390/diagnostics6030035 · Cited by 33
Zappavigna, S., Vanacore, D., Lama, S., Potenza, N., Russo, A., Ferranti, P., Dallio, M., Federico, A., Loguercio, C., Sperlongano, P., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092190 · Cited by 33
Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis
Yuan, J., Peng, G., Xiao, G., Yang, Z., Huang, J., Liu, Q., Yang, Z., & Liu, D. (2020) · Journal of Cancer · doi:10.7150/jca.33045 · Cited by 33
Zhang, K., Xi, H., Cui, J., Shen, W., Li, J., Wei, B., & Chen, L. (2015) · Europe PMC (PubMed Central) · Cited by 32
Kotowski, K. W., Supplitt, S., Wiczew, D., Przystupski, D., Bartosik, W. M., Saczko, J., Rossowska, J., Drąg‐Zalesińska, M., Michel, O., & Kulbacka, J. (2020) · Anticancer Research · doi:10.21873/anticanres.14232 · Cited by 32
Yang, J., Huo, Y., Yang, M., Shen, Y., Liu, D., Fu, X., Tao, L., He, R., Zhang, J., Hua, R., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12970 · Cited by 32
Self-citationLü, H., Yan, C. H., Quan, X., Yang, X., Zhang, J., Bian, Y., Chen, Z., & Waes, C. V. (2014) · Neoplasia · doi:10.1016/j.neo.2014.08.014 · Cited by 31
Self-citationSun, X., Yao, L., Liang, H., Wang, D., He, Y., Yao, W., Ye, L., Wang, K., Li, L., Chen, J., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0197-6 · Cited by 31
Liu, T., Huang, C., Yeh, K.-T., Ke, T., Wei, P., Yang, J.-R., & Cheng, Y. (2016) · Surgical Oncology · doi:10.1016/j.suronc.2016.05.016 · Cited by 30
Glucose starvation impairs DNA repair in tumour cells selectively by blocking histone acetylation
Ampferl, R., Rodemann, H. P., Mayer, C., Höfling, T. T. A., & Dittmann, K. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.10.020 · Cited by 30
Zhou, Y., Cheng, C., Baranenko, D. A., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010159 · Cited by 30
Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma
Oudaert, I., der Vreken, A. V., Maes, A., Bruyne, E. D., Veirman, K. D., Vanderkerken, K., & Menu, E. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00303-z · Cited by 30
Metabolic regulation of T cell development by Sin1–mTORC2 is mediated by pyruvate kinase M2
Ouyang, X., Han, Y., Qu, G., Li, M., Wu, N., Liu, H., Arojo, O., Sun, H., Liu, X., Liu, D., et al. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy065 · Cited by 29
Wiesmann, N., Strozynski, J., Beck, C., Zimmermann, N., Mendler, S., Gieringer, R., Schmidtmann, I. M., & Brieger, J. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx006 · Cited by 28
Kantarci, H., Gou, Y., & Riley, B. B. (2020) · eLife · doi:10.7554/elife.56301 · Cited by 28
Zhao, X., Tian, Z., & Liu, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.628624 · Cited by 28
Dong, D., Yao, Y., Song, J., Sun, L., & Zhang, G. (2021) · Disease Markers · doi:10.1155/2021/6645220 · Cited by 28
Therapeutic potential of targeting glucose metabolism in glioma stem cells
Nakano, I. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.944899 · Cited by 27
CUE domain‐containing protein 2 promotes the Warburg effect and tumorigenesis
Zhong, X., Tian, S., Zhang, X., Diao, X., Dong, F., Yang, J., Li, Z., Sun, L., Wang, L., He, X., et al. (2017) · EMBO Reports · doi:10.15252/embr.201643617 · Cited by 27
Klawitter, J., Klawitter, J., Gurshtein, J., Corby, K., Fong, S., Tagliaferri, M. A., Quattrochi, L. C., Cohen, I. V., Shtivelman, E., & Christians, U. (2011) · International Journal of Cancer · doi:10.1002/ijc.25965 · Cited by 26
Nuclear factor-kappa B as potential therapeutic target in human colon cancer
Plewka, D., Plewka, A., Miśkiewicz, A., Morek, M., & Bogunia, E. (2016) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.180607 · Cited by 26
Chen, Y., Wei, L., Zhang, X., Liu, X., Chen, Y., Zhang, S., Zhou, L., Li, Q., Pan, Q., Zhao, S., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6644 · Cited by 26
Annas, D., Cheon, S.-Y., Yusuf, M., Bae, S., Ha, K., & Park, K. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-77056-4 · Cited by 26
Ueyama, A., Sato, T., Yoshida, H., Magata, K., & Koga, N. (2000) · Neurosignals · doi:10.1159/000014649 · Cited by 25
Blocking PD-1/PD-L1 in Genitourinary Malignancies: To Immunity and Beyond
Dallos, M. C., & Drake, C. G. (2018) · The Cancer Journal · doi:10.1097/ppo.0000000000000302 · Cited by 25
Valproic acid suppresses Warburg effect and tumor progression in neuroblastoma
Fang, E., Wang, J., Hong, M., Zheng, L., & Tong, Q. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.103 · Cited by 25
Xu, F., Wu, H., Xiong, J., & Peng, T. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.645365 · Cited by 25
Tao, L., Moreno‐Smith, M., Ibarra‐García‐Padilla, R., Milazzo, G., Drolet, N. A., Hernandez, B. E., Oh, Y. S., Patel, I., Kim, J., Zorman, B., et al. (2021) · Advanced Science · doi:10.1002/advs.202005047 · Cited by 24
Lu, Z., Li, X., Yang, P., Mu, G., He, L., Chunmei, S., & Xu, F. (2020) · Inflammation · doi:10.1007/s10753-020-01263-4 · Cited by 23
Song, C., Li, S., Duan, F., Liu, M., Shan, S., Ju, T., Zhang, Y., & Lu, W. (2022) · Molecules · doi:10.3390/molecules27031106 · Cited by 23
He, Q., Yin, J., Zou, B., & Guo, H. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.06.005 · Cited by 22
β‐Asarone Increases Chemosensitivity by Inhibiting Tumor Glycolysis in Gastric Cancer
Tao, H., Ding, X.-L., Wu, J., Liu, S., Sun, W., Nie, M., Pan, X., & Zou, X. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/6981520 · Cited by 21
Liu, H., & Jiang, B. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-0001-5 · Cited by 16
Liu, Y., Liu, Q., Chen, D., Matsuura, A., Xiang, L., & Qi, J. (2022) · Antioxidants · doi:10.3390/antiox11020214 · Cited by 16
Monosomy-3 Alters the Expression Profile of the Glucose Transporters GLUT1-3 in Uveal Melanoma
Maaßen, T., Vardanyan, S., Brosig, A., Merz, H., Ranjbar, M., Kakkassery, V., Grisanti, S., & Tura, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249345 · Cited by 15
Lu, Y., Cheng, J. R., Cai, W., Zhuo, H., Wu, G., & Cai, J. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s292575 · Cited by 14
Covalent cell surface recruitment of chemotherapeutic polymers enhances selectivity and activity
Tomás, R. M. F., & Gibson, M. I. (2021) · Chemical Science · doi:10.1039/d0sc06580c · Cited by 12
Energy Restriction: Stepping Stones Towards Cancer Therapy
Omar, H. A., Berman-Booty, L. D., & Weng, J. (2012) · Future Oncology · doi:10.2217/fon.12.142 · Cited by 10
Autophagy in Cancer: A Metabolic Perspective
Sikder, S., Mondal, A., Das, C., & Kundu, T. K. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_5 · Cited by 7
Cited by
Lactate and lactylation in cancer
Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02082-x · Cited by 477
Metadata
- Authors
- Liao, M., Yao, D., Wu, L., Luo, C., Wang, Z., Zhang, J., & Liu, B.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2024-03
- Volume
- 14
- Issue
- 3
- Pages
- 953-1008
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W4389833823
- Cited by
- 261
- References
- 562
- FWCI
- 25.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.